|
ClinTech Research, founded
in 2005, is a New Jersey, USA-based Contract Research Organization with
a wholly owned subsidiary in India. The management team is led by Sri P Srivastava, Ph.D. CEO, who has more than 20 years of experience in drug development including discovery, preclinical toxicology & clinical operations within the US industry. Prior to founding ClinTech Research, Dr. Srivastava has held positions with progressive management responsibilities at large to mid-size multinational pharmaceutical companies like Parke-Davis, Pfizer, Purdue Pharma, and Organon Pharmaceuticals. |
 |
|
Before joining the pharmaceutical industry, Dr. Srivastava worked as a research scientist at Howard Hughes Medical Institute/ University of Michigan, Ann Arbor. He has published more than 20 publications in peer reviewed journals; and has been invited as a speaker at various national and international symposiums. Dr. Srivastava has earned his Doctor of Philosophy (Ph.D) in Biochemistry and his Master of Science (M.S) from Banaras Hindu University in India. In addition, ClinTech Research's team of advisors and consultants from the USA and India, have extensive experience in drug development including preclinical, clinical, medical and regulatory affairs. |
|